General Information of the Compound
| Compound ID |
CP0072632
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CAS_5985-38-6
Show/Hide
|
||||||||||||||||||
| Synonyms |
Antalgin
(+)-3-Hydroxy-17-methylmorphinan
(+-)-17-Methylmorphinan-3-ol
(+-)-3-Hydroxy-N-methylmorphinan
(-)-3-Hydroxy-N-methylmorphinan
(-)-N-Methylmorphinan-3-ol
1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, dl-mixture
1,3,4,9,10,10a-Hexahydro-6-hydroxy-2H-10,4a-(iminoethano)-11-methylphenanthrene
17-Methylmorphinan-3-ol
3-Hydroxy-N-methylmorphinan
Antalgin
Aromarone
Cetarin
DEA No
DEXTRORPHAN
Dextrorphan
Dl-3-Hydroxy-N-methylmorphinan
Dromoran
L-Dromoran
Levo-Dromoran
Levo-Dromoran (TN)
Levodroman
Levorfanol
Levorfanol [INN-Spanish]
Levorfanolo
Levorfanolo [DCIT]
Levorphan
Levorphanal
Levorphanol
Levorphanol (INN)
Levorphanolum
Levorphanolum [INN-Latin]
Methorfinan
Methorfinan [Czech]
Methorphinan
Morphinan-3-ol, 17-methyl-
N-Methyl-3-hydroxymorphinan
NU 2206
Orphan
Racemethorphanum
Racemic dromoran
Racemorfano
Racemorfano [INN-Spanish]
Racemorphan
Racemorphan [INN:BAN]
Racemorphane
Racemorphane [INN-French]
Racemorphanum
Racemorphanum [INN-Latin]
Ro 1-5431
dl-3-Hydroxy-N-methylmorphinan
levorphanol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H23NO
|
||||||||||||||||||
| Molecular Weight |
257.377
|
||||||||||||||||||
| Canonical SMILES |
CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc31
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JAQUASYNZVUNQP-USXIJHARSA-N
|
||||||||||||||||||
| CAS |
77-07-6
297-90-5
125-74-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT03795, Solute carrier family 22 member 1
Clinical Information about the Compound